multiFiltratePRO

multiFiltratePRO

A perfect fit for every team

  • Ergonomic design
  • Easy application of CRRT
  • Integrated Ci-Ca® anticoagulation

Key features

Key features at a glance

multiFiltratePRO acute therapy options  
  • Ci-Ca® CVVHD EMiC®2
  • Ci-Ca® CVVHD AV1000S
  • Ci-Ca® postCVVHDF
 
  • CVVHD
  • Post-CVVHDF
  • Pre-CVVHDF
  • Post-CVVH
  • Pre-CVVH
  • Pre-Post CVVH
 
Ergonomic design  
  • Large screen enables display of comprehensive information, e.g. therapy information or potential reasons in case of alarms
  • The touch screen monitor has enhanced readability from various angles
  • 4-wheel chassis with 2-stage locking system allows turning on the spot
 
Easy application of CRRT  
  • Intuitive step-by-step instructions for relevant handling situations
  • To ease handling in the ICU, fluid heaters are fully integrated into the device
  • “Care-Mode” to prevent unnecessary alarms and to save time: temporarily decreased blood flow, stopped balancing system and extended pressure limits during patient care
  • High capacity scales reduce the number of bag changes and thus user interactions
 
Comprehensive integrated Ci-Ca® anticoagulation   
  • Regional Ci-Ca® citrate anticoagulation to minimize the risk of bleeding complications 1,2,3
  • Long effective treatment times allow for efficient fluid removal via low hourly fluid removal rates; this supports hemodynamic stability 4
  • Ci-Ca® avoids downtime, thus the delivered CRRT-dose is in accordance with the prescription 4
 
multiFiltratePRO
multiFiltratePRO

Integrated Ci-Ca®

Integrated Ci-Ca® citrate anticoagulation

Statement on the Ci-Ca® protocol:

[It] enabled an effective treatment of acute renal failure and excellent control on the acid–base status as well on the systemic ionised calcium in combination with negligible clotting issues.2

Intelligent software support

Ci-Ca® protocol included in the software

multiFiltratePRO CiCa HD screen
Screen during Ci-Ca® CVVHD application provides key information from the Ci-Ca® protocol
Supports the user with expert information and features
For routine adjustments of the Ci-Ca® therapy, information from the protocol can easily be retrieved on the screen
In case of certain values set outside the standard range, the multiFiltratePRO makes the user aware of potentially risky clinical situations

Dedicated hardware components for citrate anticoagulation

Clear allocation of functionality

Dedicated pumps for citrate and calcium keep the syringe pump available for heparin application if needed during Ci-Ca® therapy. Separate level detectors and drip counters enable timely detection of empty bags, preventing air being transported downstream and enabling a smooth continuation of the treatment. During bag changes (dialysate, substituate, filtrate) the citrate infusion continues for a reliable period of time. This helps to avoid early coagulation of the system

Nurse operating multiFiltratePRO device
Nurse operating multiFiltratePRO device

Therapy kits

Complete kits for multiFiltratePRO

All you need in one box

Each treatment kit contains the tubing and filter you need for the respective treatment − and nothing more. This helps to protect the environment and to save you costs.

Ci-Ca® treatment kits for multiFiltratePRO

Ci-Ca® CVVHD

Ci-Ca® CVVHD treatment
multiFiltratePRO - Kit Ci-Ca® HD EMiC®2
multiFiltratePRO - Kit Ci-Ca® HD 1000

Ci-Ca® post-CVVHDF

Ci-Ca® post-CVVHDF treatment
multiFiltratePRO - Kit Ci-Ca® HDF 1000

Usage of multiFiltratePRO– Kit HDF 1000

  • CVVHD

  • Post-CVVHDF

  • Pre-CVVHDF

  • Post-CVVH

  • Pre-CVVH

  • Pre-Post CVVH

multiFiltratePRO kit guideline chart

Technology

Large and adjustable monitor

multiFiltratePRO monitor
multiFiltratePRO monitor
multiFiltratePRO monitor

Advanced graphic user interface

multiFiltratePRO interface
multiFiltratePRO interface

The multiFiltratePRO includes a graphic user interface that monitors and displays all relevant set-up and treatment data. The integrated alarm system helps to quickly determine the urgency as well as the root cause of alarms.

The time until the next expected user action is displayed in the status bar at the top right of the screen. In addition, a list of further upcoming user interactions can be retrieved on the screen. Both help to optimize work processes in the ICU.

The “Care Button” switches the multiFiltratePRO into care-mode, by decreasing the blood flow, stopping the balancing system and extending the pressure limits. This will prevent unnecessary alarms when moving the patient or manipulating the catheter.

Easy application of CRRT

Device-supported set-up process

multiFiltratePRO blood pump
multiFiltratePRO blood pump: Fitting the pump positioners automatically triggers the insertion of the pump segment. The corresponding pressure domes open and guide the correct installation of the tubing. Multiple automated tests accompany the set-up process, keeping the user on the right track. As a result, the number of handling steps is reduced.

Long intervals between bag changes

multiFiltratePRO- bag changes chart
multiFiltratePRO with large-scale capacity: The scales for fresh CRRT fluid and for filtrate can hold up to 20 L fluid each, resulting in long time intervals between bag changes. For these scales, one bag change is typically sufficient per 8h nursing shift.

Related content

CRRT set-ups
CRRT set-ups

Different options as standard therapies for acute kidney injury.

1 KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements 2012. 2:1-138
2 Morgera S et al., A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Critical Care Medicine 2009. 37:2018-24
3 Morgera S et al., Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clinical Practice 2004. 97:c131-6
4 Kalb R et al., Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk. Therapeutic Apheresis and Dialysis 2013. 17:202-12